Pulmovant, Inc.
Clinical trials sponsored by Pulmovant, Inc., explained in plain language.
-
New inhaled therapy shows promise for Hard-to-Treat lung condition
Disease control OngoingThis study tests an inhaled medicine called mosliciguat in 135 people who have high blood pressure in their lungs due to scarring lung disease. The goal is to see if it improves blood flow and walking ability over 16 weeks. Participants are randomly assigned to receive the drug o…
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Healthy men help scientists track new Drug's journey through the body
Knowledge-focused OngoingThis early-stage study involves 8 healthy adult men to understand how the experimental drug mosliciguat is absorbed, broken down, and removed from the body. Participants receive the drug by inhalation, injection, and mouth over three periods. The goal is to measure drug levels an…
Phase: PHASE1 • Sponsor: Pulmovant, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 02:04 UTC